This suggested the possibility that the expression of CA-IX may serve as a useful biomarker for diagnosing AIS and adenocarcinoma (Liao et al, 1994, 2009; Liao and Stanbridge, 1996, 2000). This evidence concerns the gene CA9 and adenocarcinoma.